Chronic Cholecystitis

5

Review clinical trials related to Chronic Cholecystitis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Probiotic Yogurt in Patients With Chronic Cholecystitis

Background and Purpose: Chronic cholecystitis is a common disease causing gallbladder inflammation, which is closely related to imbalances in gut bacteria and bile acids. This study aims to investigate whether consuming a special functional yogurt containing the probiotic Pediococcus acidilactici GR-5 can help alleviate the symptoms of chronic cholecystitis. Study Procedures: Researchers will recruit 50 patients with chronic cholecystitis and randomly divide them into two groups. For 30 days, one group will consume the functional GR-5 probiotic yogurt, while the other group will consume regular commercial yogurt (placebo). During the study period, researchers will use abdominal imaging to check the gallbladder, evaluate clinical symptoms, and collect blood and stool samples at baseline and after the 30-day intervention. The goal is to see if this probiotic yogurt can improve gallbladder health by regulating gut bacteria and bile acid metabolism, potentially providing a new dietary and nutritional option for patients with cholecystitis.

Participants needed: 50
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: LanZhou UniversityUpdated: Jun 17, 2026Locations: 1
Eligibility criteria

Male or female, aged 18 to 70 years. [+4]

Acute exacerbation of cholecystitis, purulent or gangrenous cholecystitis, or ac... [+6]

Status: Recruiting

Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers

This open-label study will evaluate the effect of food on the bioavailability of a single dose of 4-MUST, tablets, 128 mg. Additionally, the study will assess the pharmacokinetics, safety, and tolerability of 4-MUST, tablets, 128 mg following both single and multiple oral dose administration.

Participants needed: 45
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Valenta Pharm JSCUpdated: Jun 15, 2026Locations: 1
Eligibility criteria

Voluntary, personally signed ICF obtained prior to any study procedures; [+37]

Voluntary withdrawal of the subject from the study; [+11]

Status: Recruiting

Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia

The aim of the study is to evaluate the efficacy, safety, and tolerability of 4-MUST, 128 mg tablets compared to placebo in patients with chronic cholecystitis and biliary dyskinesia.

Participants needed: 300
Trial details
Phase: Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Valenta Pharm JSCUpdated: May 19, 2026Locations: 10
Eligibility criteria

Males and females aged 18-70 years. [+43]

Incorrect enrollment of a patient in the study (failure to meet inclusion/exclus... [+11]

Status: Recruiting

Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia

This study aims to evaluate the efficacy, safety, and tolerability of the drug 4-MUST at various doses compared to placebo in patients with chronic cholecystitis and biliary dyskinesia

Participants needed: 300
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Valenta Pharm JSCUpdated: Jul 11, 2025Locations: 17
Eligibility criteria

Males and females aged 18-70 years. [+39]

Incorrect enrollment of a patient in the study (failure to meet inclusion/exclus... [+10]

Status: Not yet recruiting

An Assessment of the Effectiveness (Efficacy) of Odeston (Odeston®) in Patients With Chronic Cholecystitis in Real Medical Practice

Post-marketing Observational Clinical Study: Assessment of the Effectiveness (Efficacy) of Odeston (Odeston®) in Patients With Chronic Cholecystitis in Real Medical Practice

Participants needed: 169
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Kazakhstan Scientific Society for Study of intestine diseasesUpdated: Jul 24, 2024Locations: 15
Eligibility criteria

Men and women aged 18 to 65 years; [+3]

Presence of stones in the gall bladder and bile ducts; [+15]